This study, which is continuing, was designed to investigate the pharmacokinetics of cefuroxime in the biliary tract of patients with either functioning or non-functioning gall bladders. The bacteriological and pharmacological properties of cefuroxime suggest that it should be an effective agent in the treatment of biliary tract infections (O'Callaghan et at. 1976).
Patients and Methods
Twenty-two patients requiring cholecystectomy for cholecystitis entered the first part of the study, designed to determine cefuroxime levels in bile from the gall bladder and common bile duct. The 16 female and 6 male patients ranged in age from 22-73 years. Four patients with T-tubes inserted into the bile duct were entered into the second part of the study, for the determination of serial bile levels following a single dose of cefuroxime. In these 1 male and 3 female patients (aged 41-74 years) operative cholangiography demonstrated the presence of stones in the common bile duct and, after exploration of the ducts, T-tubes were inserted. No patients were included if they had proven or suspected hypersensitivity to cephalosporins or penicillins, or if they had abnormal liver or renal function.
Cholecystectomy Study Prior to operation, the patients were given 3 doses of 750 mg of cefuroxime i.m. into the buttock at 8 hourly intervals. The third and final dose was given with the premedication. The first blood sample (Serum 1) was taken at the beginning of the operation, which was about 2 h after the last dose of cefuroxime. Bile specimens were obtained by needle puncture from the gall bladder and, when possible, from the bile duct when it was catheterized for preoperative cholangiography. The second blood sample (Serum 2) was taken at the same time as the bile specimens. The timing of these specimens varied with the ease of operation, but weie usually taken about 0.5 h after Serum 1. A third blood sample (Serum 3) was taken 1 h after Serum 2 if possible.
T-tube Study
When the patients from this study had recovered from their operations and were back on a normal diet, each was given a single i.m. injection of 750 mg of cefuroxime. Serum and bile specimens were then collected at hourly intervals for 6 h.
Assays of serum and bile samples were carried 
Results
For assessment, the patients were divided into 2 groups based on the pre-operative cholecystograms. This radiological examination indicated that 17 of the 22 patients had functioning gall bladders at the time of cholecystectomy. The remaining 5 patients had non-functioning gall bladders, presumably due to blocked cystic ducts. Fig 1 shows the mean serum and gall bladder bile levels for 13 of the 17 patients with functioning gall bladders. Four patients have been excluded because they did not receive the final pre-operative dose of cefuroxime. The mean serum levels of 12.5, 8.8 and 5.6 mg/l for Serum 1, 2 and 3 respectively are consistent with samples being taken at approximately 2, 2.5 and 3.5 h after injection of 750 mg of cefuroxime. The ranges were 7.0-20.0, 2.2-16.5 and 3.9-7.5 mg/l respectively for the 3 serum samples. Table 1 Cefuroxime levels (mg/I) in 5 patients with radiologically non-functioning gall bladders The gall bladder bile levels showed a wide variation from 1.2-58.0 mg/I, presumably due to a variation in gall bladder function and in sampling time. Problems were encountered in aspirating the normal calibre common bile duct, which meant that samples were obtained only in 4 of the 13 patients who received all the doses of cefuroxime. The cefuroxime levels in the common duct bile for these 4 patients were 3.1, 14.0, 12.0 and 24.0 mg/I, with a mean of 13.2 mg/l, compared with the mean level in the gall bladder of 29 mg/l. Table 1 shows the bile and serum levels for the 5 patients classified as having radiologically nonfunctioning gall bladders. The biliary levels of cefuroxime in 3 patients are in keeping with non-function of the gall bladder, whereas the levels recorded for the other 2 patients indicate that there was some gall bladder function. 
Discussion
The biliary levels after 3 doses of cefuroxime from all except 2 patients with functioning gall bladders exceeded the minimum inhibitory concentrations of many common gall bladder pathogens including Escherichia coli and Salmonella spp. (O'Callaghan et al. 1976 ).
The series of 5 patients with radiologically non-functioning gall bladders is too small to produce conclusive results. However, the results suggest that cefuroxime is not concentrated in the non-functioning gall bladder.
The T-tube results show that cefuroxime is rapidly excreted in the bile, peak levels occurring approximately I h after those in the serum. Five h after administration of the dose, bile levels still exceeded the MIC of most of the common bile organisms and Salmonella.
We intend to study more patients with reduced gall bladder function and also add more patients to our T-tube study. 
DISCUSSION
Dr P W Muggleton (Greenford) said that in selecting their patients, several investigators had excluded those with a known history of allergy to penicillin or other cephalosporins. However, there did not appear to be much logic in doing so. They had extensively studied sensitivity to cefuroxime in laboratory animals and found that antibodies could be raised to it only with extreme difficulty. The antibiotic had to be coupled to foreign serum albumin using, for example, glutaraldehyde. Using such an antibody to perform PCA tests in guinea pigs sensitization was achieved, but there was no cross-reaction with any other cephalosporin (including cephalothin, cephaloridine or cephalexin) nor with penicillin either. He therefore questioned the validity of excluding patients with cephalosporins or penicillin allergy from the investigations.
Professor G K Daikos (Athens) said that they had not hesitated in giving cefuroxime to 3 patients who had anaphylactic shock to penicillin and-they received it very well. He was pleased to hear that it did not cross-react with other cephalosporins.
Cefuroxime
Dr S H Ng (Orpington) wondered how investigators had reacted to the finding of a positive Coombs' test and whether the test results became negative on cessation of treatment.
He also drew attention to the fall in hmmoglobin recorded by some investigators at the end of treatment. In his view, quite apart from the antibiotic, it was necessary to consider the fact that a considerable amount of blood was being removed from these patients as part of the investigation, in addition to which a good deal of hamolysis occurred as a result of infection itself.
Dr R N Pearson (London) had observed a fall in hemoglobin but only very slight changes in AST and bilirubin following 5 days of cefuroxime treatment for chest infection. The patient's renal function as judged by creatinine, plasma urea and creatinine clearance values had improved, and he wondered whether the lower htmoglobins observed at the end of the treatment were related not so much to hemolysis as to rehydration of the patients. The differences he observed were quite compatible with this hypothesis.
Dr de Meutter said that their one patient with cirrhosis had a Coombs' test which was negative before and during treatment but positive afterwards.
Dr Gobernado had found no positive Coombs' tests although they had not looked for them systematically but only in those patients showing a decrease in hemoglobin. Nonetheless the patients were ill and it was difficult to ascribe hemoglobin falls to the administration the of drug.
Professor Stille (Chairman) said that positive Coombs' tests were quite common with other cephalosporins. It was not a harmful side effect and it had to be differentiated from a real positive Coombs' tests in hemolytic anrmia.
Dr S H Zinner (Rhode Island) asked if any data existed on bile levels in acute cholecystitis. Did the inflamed gall bladder admit more or less cefuroxime than the chronic gall bladder ?
Mr J E L Sales said he did not know of any direct studies on this question. However, in patients with acute cholecystitis, the cystic duct was blocked and presumably very little of the antibiotic could be transported in via the bile. Investigators analysing the concentration in the gall bladder wall had also found it to be low. On removing the chronically inflamed gall bladder there was usually not much mucosa left and it had a very fibrous structure. The blood supply to the chronically inflamed gall bladder was also reduced and he thought that the penetration of the antibiotic in such conditions was probably very low.
Mr S A J Powis (Northampton) had looked at the levels of sodium cefazolin in acute cholecystitis and the levels were generally low. The cystic duct was blocked and the quantities were never as high as those seen in the functioning gall bladder.
The surgeon's main concern was to remove the obstruction. The bile would then become sterile. However, one concern was to prevent wound infection, and in at least 40% of patients wound infection was due to the same organisms as those found in bile. It was therefore most important to obtain high tissue levels at the time of possible contamination with bile in an effort to prevent wound infection. His experience had supported this suggestion, because the wound infection rate had fallen from 16 % in controls to 3 % in treated patients.
Professor Stille (Chairman) endorsed this remark. Treatment of biliary infection concerned more factors than the activity in the bile. Tissue levels must not be forgotten.
